Assignee
FNCT BIOTECH INC
KR·1 granted patent·5 pending applications·0 citations·filing 2020–2024
Top patents by PatentIndex Score
6 records- 0167US11787856B2Use of G-CSF antibody for treatment of pulmonary fibrosisFNCT BIOTECH INC·Filed 2023·Granted Oct 17, 2023·0 cites·7 claims
- 0266US2024352116A1Use of m-csf or g-csf for diagnosis or treatment of pulmonary fibrosisFNCT BIOTECH INC·Filed 2024·Application pending·0 cites
- 0351US2025376515A1Use of m-csf or g-csf for diagnosis or treatment of pulmonary fibrosisFNCT BIOTECH INC·Filed 2020·Application pending·0 cites
- 0448US2023288399A1Method for screening colorectal cancer metastasis inhibitorFNCT BIOTECH INC·Filed 2021·Application pending·0 cites
- 0545US2025122293A1Csf3r as biomarker and therapeutic target for pulmonary fibrosisFNCT BIOTECH INC·Filed 2022·Application pending·0 cites
- 0641US2023399392A1Composition for preventing or treating pulmonary fibrosis diseaseFNCT BIOTECH INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →